雅居樂集團(03383.HK)回購及轉售5.7億元公司債券
格隆匯10月17日丨雅居樂集團(03383.HK)公告,於2016年9月29日刊發有關發行於2021年到期總金額人民幣18億元初始年度票面利率為4.60%的非公開境內公司債券。
根據《雅居樂集團控股有限公司非公開發行2016年公司債券募集説明書(第二期)》的相關條款,境內債券持有人可在回售登記期(即2019年9月9日至2019年9月11日)對所持境內債券進行全部或部分的回售申報登記,回售價為境內債券的面值,即每張人民幣100元。
已於2019年10月11日完成對570萬張境內債券合共金額為人民幣5.7億元的回購。完成是次回購後,公司已全數轉售該等570萬張境內債券。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.